Company: ARMP
Filing Date: 2025-08-13
Form Type: S-3
Source: 0001104659-25-077648
Chunk: 37

Company: Armata Pharmaceuticals, Inc.
Filing Date: 2025-08-13
Form: S-3
Chunk 37
---
 purchased 
 by each of them;                                    |

| · | the purchase price of securities and the proceeds 
 we will receive from the sale;                    |

| · | any option under which underwriters may purchase 
 additional securities from us;                   |

| · | any underwriting discounts or commissions or                                    
 agency fees and other items constituting underwriters’ or agents’ compensation; |

| · | the public offering price of the securities; |

| · | any discounts, commissions or concessions allowed 
 or reallowed or paid to dealers; and              |

| · | any securities exchange or market on which the 
 securities may be listed.                      |

Any public offering price
and any discounts or concessions allowed or reallowed or paid to dealers may be changed from time to time. We may determine the price
or other terms of the securities offered under this prospectus by use of an electronic auction. We will describe how any auction will
determine the price or any other terms, how potential investors may participate in the auction and the nature of the obligations of the
underwriter, dealer or agent in the applicable prospectus supplement.

Underwriters or dealers may
offer and sell the offered securities from time to time in one or more transactions, including negotiated transactions, at a fixed public
offering price or at varying prices determined at the time of sale. If underwriters or dealers are used in the sale of any securities,
the securities will be acquired by the underwriters or dealers for their own account and may be resold from time to time in one or more
transactions described above. The securities may be either offered to the public through underwriting syndicates represented by managing
underwriters, or directly by underwriters or dealers. Generally, the underwriters’ or dealers’ obligations to purchase the
securities will be subject to certain conditions precedent. The underwriters or dealers will be obligated to purchase all of the securities
if they purchase any of the securities, unless otherwise specified in the prospectus supplement. We may use underwriters with whom we
have a material relationship. We will describe the nature of any such relationship in the prospectus supplement, naming the underwriter.

We may sell the securities
through agents from time to time. The prospectus supplement will name any agent involved in the offer or sale of the securities and any
commissions we pay to them. Generally, any agent will be acting on a best efforts basis for the period of its appointment. We may authorize
underwriters, dealers or agents to solicit offers by certain purchasers